Literature DB >> 16309513

Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas.

N Rajan, J A A Langtry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16309513     DOI： 10.1111/j.1365-2230.2005.01938.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  29 in total

Review 1.  Pattern recognition receptors in immune disorders affecting the skin.

Authors:  Heleen D de Koning; Anna Simon; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Innate Immun       Date:  2012-03-06       Impact factor: 7.349

Review 2.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 3.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.

Authors:  Luigi Tortola; Esther Rosenwald; Brian Abel; Hal Blumberg; Matthias Schäfer; Anthony J Coyle; Jean-Christoph Renauld; Sabine Werner; Jan Kisielow; Manfred Kopf
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

5.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.

Authors:  Yihua Cai; Xiaoyan Shen; Chuanlin Ding; Chunjian Qi; Kejia Li; Xia Li; Venkatakrishna R Jala; Huang-ge Zhang; Tian Wang; Jie Zheng; Jun Yan
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

6.  A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia.

Authors:  William M Gordon; Michael D Zeller; Rachel H Klein; William R Swindell; Hsiang Ho; Francisco Espetia; Johann E Gudjonsson; Pierre F Baldi; Bogi Andersen
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

7.  Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?

Authors:  Joselin D Tacastacas; Patricia Oyetakin-White; David C Soler; Andrew Young; Sarah Groft; Kord Honda; Kevin D Cooper; Thomas S McCormick
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-04-20       Impact factor: 3.135

8.  Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.

Authors:  Lynda Grine; Lien Dejager; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

9.  Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.

Authors:  Sirish K Ippagunta; Ruchika Gangwar; David Finkelstein; Peter Vogel; Stephane Pelletier; Sebastien Gingras; Vanessa Redecke; Hans Häcker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

10.  Topical heat shock protein 70 prevents imiquimod-induced psoriasis-like inflammation in mice.

Authors:  Federico G Seifarth; Julia E-M Lax; Jennifer Harvey; Paul E DiCorleto; M Elaine Husni; Unnikrishnan M Chandrasekharan; Michael Tytell
Journal:  Cell Stress Chaperones       Date:  2018-04-03       Impact factor: 3.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.